Technical Analysis for ACRS - Aclaris Therapeutics, Inc.
|Grade||Last Price||% Change||Price Change|
ACRS closed down 6.51 percent on Wednesday, January 16, 2019, on approximately normal volume. Due to the stock's strong downtrend, it may remain oversold for a while. So, if you're looking for a reason to buy, don't put too much weight on it being oversold.
|See historical ACRS trend table...|
|Date||Alert Name||Type||% Chg|
|Jan 16||Oversold Stochastic||Weakness||0.00%|
|Jan 15||Doji - Bullish?||Reversal||-6.51%|
|Jan 15||Stochastic Reached Oversold||Weakness||-6.51%|
|Jan 15||Oversold Stochastic||Weakness||-6.51%|
|Jan 14||20 DMA Resistance||Bearish||-5.83%|
|Jan 14||180 Bearish Setup||Bearish Swing Setup||-5.83%|
|Jan 14||Outside Day||Range Expansion||-5.83%|
|Jan 14||Down 3 Days in a Row||Weakness||-5.83%|
|Jan 14||Down 4 Days in a Row||Weakness||-5.83%|
|Jan 14||Down 5 Days in a Row||Weakness||-5.83%|
Get a Trading Sidekick!
Let us help you stay on top of your investments. We will alert you to important technical developments on your portfolio & watchlist.
Configure default chart indicatorsBasic chart:
Aclaris Therapeutics, Inc., a clinical-stage specialty pharmaceutical company, focuses on identifying, developing, and commercializing topical drugs to address various unmet needs in dermatology. Its lead drug candidate is A-101, a hydrogen peroxide topical solution that has completed three Phase II clinical trials for the treatment of seborrheic keratosis (SK), a common non-malignant skin tumor. The company is also developing A-101 as a prescription treatment for common warts; and A-102, a proprietary topical gel dosage form of hydrogen peroxide for the treatment of SK and common warts. Aclaris Therapeutics, Inc. was founded in 2012 and is headquartered in Malvern, Pennsylvania.
|Indicator||Bull Case||Neutral / Hold||Bear Case|
|Oversold / Overbought|
|Summary:||Counts: 0 bullish, 4 bearish and 1 neutral indicators. You may wish to incorporate that into your trading strategies.|
See more ACRS news...
|52 Week High||25.89|
|52 Week Low||6.15|
|200-Day Moving Average||14.8752|
|50-Day Moving Average||8.3823|
|20-Day Moving Average||7.1425|
|10-Day Moving Average||7.248|
|Average True Range||0.4796|
|Chandelier Exit (Long, 3 ATRs )||6.7512|
|Chandelier Exit (Short, 3 ATRs )||7.5888|
|Upper Bollinger Band||7.9293|
|Lower Bollinger Band||6.3557|
|Percent B (%b)||0.07|
|MACD Signal Line||-0.4339|
|Market Cap||172.71 Million|
|Num Shares||26.7 Million|
|Price-to-Earnings (P/E) Ratio||-3.18|
|Pivot Point Level||Traditional / Classic||Fibonacci||Demark||Woodie||Camarilla|
|Resistance 4 (R4)||7.25|
|Resistance 3 (R3)||7.32||7.13||7.12|
|Resistance 2 (R2)||7.13||6.93||7.09||7.07|
|Resistance 1 (R1)||6.80||6.81||6.70||6.72||7.03|
|Support 1 (S1)||6.27||6.40||6.18||6.20||5.89|
|Support 2 (S2)||6.08||6.28||6.04||5.85|
|Support 3 (S3)||5.75||6.08||5.80|
|Support 4 (S4)||5.67|